| 规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
|---|---|---|---|---|---|---|---|---|---|
| 5mg | ¥ žžȇųȇȇ | > 10 | -- | -- | -- | -- | -- | ¥ žžȇųȇȇ | - + |
| 10mg | ¥ ũǯŎĨųȇȇ | > 10 | -- | -- | -- | -- | -- | ¥ ũǯŎĨųȇȇ | - + |
110.6
[1]. Ali S, et al. Selected replicon variants with low-level in vitro resistance to the hepatitis C virus NS5B polymerase inhibitor PSI-610 lack cross-resistance with R149. Antimicrob Agents Chemother. 008 Dec;5(1):456-69.
[]. Ma H, et al. Characterization of the metabolic activation of hepatitis C virus nucleoside inhibitor beta-D- -Deoxy- -fluoro- -C-methylcytidine (PSI-610) and identification of a novel active 5 -triphosphate species. J Biol Chem. 00 Oct 1;8(41):981-0. Epub 00 Aug 1.
H0-H15-H19-H5
P61-P64-P0-P1-P80-P0+P5-P04+P40-P05+P51+P8-P0-P6+P64-P40+P-P405-P501
GHS0
![]()
![]()